Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1997 1
1998 3
1999 1
2000 1
2001 1
2002 2
2003 3
2004 6
2005 4
2006 5
2007 7
2008 7
2009 6
2010 5
2011 7
2012 10
2013 9
2014 12
2015 16
2016 16
2017 14
2018 19
2019 10
2020 23
2021 26
2022 17
2023 17
2024 16
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

230 results

Results by year

Filters applied: . Clear all
Page 1
Ruxolitinib for pediatric patients with treatment-naïve and steroid-refractory acute graft-versus-host disease: the REACH4 study.
Locatelli F, Kang HJ, Bruno B, Gandemer V, Rialland F, Faraci M, Takahashi Y, Koh K, Bittencourt H, Cleary G, Rosko C, Li X, St Pierre A, Prahallad A, Diaz-de-Heredia C. Locatelli F, et al. Among authors: gandemer v. Blood. 2024 Nov 14;144(20):2095-2106. doi: 10.1182/blood.2023022565. Blood. 2024. PMID: 39046767 Free article. Clinical Trial.
[GroupOs welcomed guidelines].
Orbach D, Gandemer V, Pellier I. Orbach D, et al. Among authors: gandemer v. Bull Cancer. 2025 Jun;112(6):569-570. doi: 10.1016/j.bulcan.2025.02.003. Epub 2025 Mar 7. Bull Cancer. 2025. PMID: 40057425 French. No abstract available.
NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients.
Simonin M, Vasseur L, Lengliné E, Lhermitte L, Cabannes-Hamy A, Balsat M, Schmidt A, Dourthe ME, Touzart A, Graux C, Grardel N, Cayuela JM, Arnoux I, Gandemer V, Huguet F, Ducassou S, Lhéritier V, Chalandon Y, Ifrah N, Dombret H, Macintyre E, Petit A, Rousselot P, Lambert J, Baruchel A, Boissel N, Asnafi V. Simonin M, et al. Among authors: gandemer v. Blood. 2024 Oct 10;144(15):1570-1580. doi: 10.1182/blood.2023023754. Blood. 2024. PMID: 38848537
Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.
Micol R, Ben Slama L, Suarez F, Le Mignot L, Beauté J, Mahlaoui N, Dubois d'Enghien C, Laugé A, Hall J, Couturier J, Vallée L, Delobel B, Rivier F, Nguyen K, Billette de Villemeur T, Stephan JL, Bordigoni P, Bertrand Y, Aladjidi N, Pedespan JM, Thomas C, Pellier I, Koenig M, Hermine O, Picard C, Moshous D, Neven B, Lanternier F, Blanche S, Tardieu M, Debré M, Fischer A, Stoppa-Lyonnet D; CEREDIH Network Investigators. Micol R, et al. J Allergy Clin Immunol. 2011 Aug;128(2):382-9.e1. doi: 10.1016/j.jaci.2011.03.052. Epub 2011 Jun 12. J Allergy Clin Immunol. 2011. PMID: 21665257
Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
Zsiros J, Brugieres L, Brock P, Roebuck D, Maibach R, Zimmermann A, Childs M, Pariente D, Laithier V, Otte JB, Branchereau S, Aronson D, Rangaswami A, Ronghe M, Casanova M, Sullivan M, Morland B, Czauderna P, Perilongo G; International Childhood Liver Tumours Strategy Group (SIOPEL). Zsiros J, et al. Lancet Oncol. 2013 Aug;14(9):834-42. doi: 10.1016/S1470-2045(13)70272-9. Epub 2013 Jul 4. Lancet Oncol. 2013. PMID: 23831416 Free PMC article.
[A 2021 inventory in oncology news].
Bay JO, Bouleuc C, Firmin N, Gandemer V, Magne N, Orbach D, Penel N, Rodrigues M, Thiery-Vuillemin A, Wislez M, L'Allemain G, Sabatier R, Robert J; comité de rédaction du Bulletin du Cancer. Bay JO, et al. Among authors: gandemer v. Bull Cancer. 2022 Jan;109(1):8-19. doi: 10.1016/j.bulcan.2021.12.003. Epub 2021 Dec 31. Bull Cancer. 2022. PMID: 34980367 Review. French.
Childhood Langerhans cell histiocytosis hematological involvement: severity associated with BRAFV600E loads.
Thalhammer J, Jeziorski E, Marec-Bérard P, Barkaoui MA, Pagnier A, Rohrlich PS, Chevallier A, Carausu L, Aladjidi N, Rigaud C, Leruste A, Azarnoush S, Lauvray T, Le Louet S, Gandemer V, Treguier P, Mansuy L, Pasquet M, Olivier L, Rome A, Saultier P, Isfan F, Renard C, Li Thiao Te V, Salmon A, Blanc L, Abou Chahla W, Lambilliotte A, Stephan JL, Geissmann F, Lejeune J, Mallebranche C, Reguerre Y, Grain A, Thomas C, Hélias-Rodzewicz Z, Moshous D, Fenneteau O, Coulomb-L'Hermine A, Lapillonne H, de Saint-Basile G, Emile JF, Héritier S, Donadieu J. Thalhammer J, et al. Among authors: gandemer v. Blood. 2025 Mar 6;145(10):1061-1073. doi: 10.1182/blood.2024025625. Blood. 2025. PMID: 39486044 Free article.
Long-term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium.
Sicre de Fontbrune F, Chevillon F, Fahd M, Desseaux K, Poiré X, Forcade E, Sterin A, Neven B, Gandemer V, Thepot S, Garnier A, Lioure B, Marcais A, Nguyen-Quoc S, Tavitian S, Vincent L, Donadieu J, Resche Riggon M, Chevret S, Pasquet M, Peffault de Latour R. Sicre de Fontbrune F, et al. Among authors: gandemer v. Br J Haematol. 2024 Aug 19. doi: 10.1111/bjh.19691. Online ahead of print. Br J Haematol. 2024. PMID: 39159950
Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials.
Choderlos de Laclos X, Risbourg S, Brennan B, Bertucci F, Gaspar N, Gelderblom H, Hawkins DS, Janeway K, Juergens H, Kasper B, Krailo MD, Cécile Le Deley M, Marec-Bérard P, McCabe MG, Metzler M, Ranft A, Strauss S, Tabone MD, Windsor R, Dirksen U, Gandemer V. Choderlos de Laclos X, et al. Among authors: gandemer v. Eur J Cancer. 2024 Sep;208:114229. doi: 10.1016/j.ejca.2024.114229. Epub 2024 Jul 15. Eur J Cancer. 2024. PMID: 39032218 Free PMC article. Clinical Trial.
[A 2023 inventory in oncology news].
Bay JO, Auberger B, Bouleuc C, Cohen R, Delom F, Firmin N, Gandemer V, L'Allemain G, Magne N, De Nonneville A, Orbach D, Pellier I, Rodrigues M, Wislez M; pour le comité de rédaction du Bulletin du Cancer. Bay JO, et al. Among authors: gandemer v. Bull Cancer. 2024 Jan;111(1):18-32. doi: 10.1016/j.bulcan.2023.12.003. Epub 2024 Jan 5. Bull Cancer. 2024. PMID: 38184423 Review. French.
230 results